• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冷缺血时间和/或福尔马林固定对乳腺癌中雌激素受体、孕激素受体及人表皮生长因子受体-2检测结果的影响

The Effect of Cold Ischemia Time and/or Formalin Fixation on Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor-2 Results in Breast Carcinoma.

作者信息

Pekmezci Melike, Szpaderska Anna, Osipo Clodia, Erşahin Cağatay

机构信息

Department of Pathology, Loyola University Medical Center, Maywood, IL 60153, USA.

出版信息

Patholog Res Int. 2012;2012:947041. doi: 10.1155/2012/947041. Epub 2012 Mar 11.

DOI:10.1155/2012/947041
PMID:22482085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3317053/
Abstract

Aims. To compare the results of estrogen and progesterone receptors (ER, PR), and human epidermal growth factor receptor-2 (HER2) expression status on biopsy and excision specimens and to evaluate the effect of cold ischemia time and/or formalin fixation on these biomarkers. Methods. Breast carcinomas that were diagnosed between 2007 and 2009 by core needle biopsy, and subsequently excised in our institution, were included in the study. Data regarding the tumor morphology, grade, and ER, PR, and HER2 status were retrospectively collected from the pathology reports. Results. Five out of 149 (3.4%) cases with ER-positive receptor status in the biopsy specimen became ER-negative in the subsequent excision specimen. Nine out of 126 (7.1%) cases with PR-positive receptor status in the biopsy specimen became PR-negative in the excision specimen. Receptor status change was predominantly seen in tumors with low ER and PR receptor expression. HER2 results were consistent between biopsy and excision specimens in all cases tested. Conclusions. Cold ischemia time and/or formalin fixation affect mainly ER and PR testing with low Allred scores and support the implementation of the ASCO/CAP guidelines. HER2 results, however, were not affected in our limited number of patients.

摘要

目的。比较活检和切除标本中雌激素受体(ER)、孕激素受体(PR)以及人表皮生长因子受体2(HER2)的表达结果,并评估冷缺血时间和/或福尔马林固定对这些生物标志物的影响。方法。纳入2007年至2009年间经粗针活检诊断并随后在本机构接受切除的乳腺癌病例。从病理报告中回顾性收集有关肿瘤形态、分级以及ER、PR和HER2状态的数据。结果。活检标本中ER受体状态为阳性的149例病例中有5例(3.4%)在随后的切除标本中变为ER阴性。活检标本中PR受体状态为阳性的126例病例中有9例(7.1%)在切除标本中变为PR阴性。受体状态改变主要见于ER和PR受体表达较低的肿瘤。在所有检测病例中,活检和切除标本的HER2结果一致。结论。冷缺血时间和/或福尔马林固定主要影响低Allred评分的ER和PR检测,并支持美国临床肿瘤学会/美国病理学家学会(ASCO/CAP)指南的实施。然而,在我们数量有限的患者中,HER2结果未受影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8786/3317053/40240fdfaba0/PRI2012-947041.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8786/3317053/40240fdfaba0/PRI2012-947041.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8786/3317053/40240fdfaba0/PRI2012-947041.001.jpg

相似文献

1
The Effect of Cold Ischemia Time and/or Formalin Fixation on Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor-2 Results in Breast Carcinoma.冷缺血时间和/或福尔马林固定对乳腺癌中雌激素受体、孕激素受体及人表皮生长因子受体-2检测结果的影响
Patholog Res Int. 2012;2012:947041. doi: 10.1155/2012/947041. Epub 2012 Mar 11.
2
Immunohistochemical detection of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 in formalin-fixed breast carcinoma cell block preparations: correlation of results to corresponding tissue block (needle core and excision) samples.福尔马林固定乳腺癌细胞块标本中雌激素受体、孕激素受体及人表皮生长因子受体2的免疫组化检测:结果与相应组织块(针芯活检及切除活检)样本的相关性
Diagn Cytopathol. 2013 Mar;41(3):192-8. doi: 10.1002/dc.21815. Epub 2012 May 21.
3
Reflex Estrogen Receptor (ER) and Progesterone Receptor (PR) Analysis of Ductal Carcinoma In Situ (DCIS) in Breast Needle Core Biopsy Specimens: An Unnecessary Exercise That Costs the United States $35 Million/y.乳腺针吸活检标本中导管原位癌(DCIS)的雌激素受体(ER)和孕激素受体(PR)反射分析:一项每年耗费美国3500万美元的不必要操作。
Am J Surg Pathol. 2016 Aug;40(8):1090-9. doi: 10.1097/PAS.0000000000000674.
4
Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor-2 Testing in Breast Cancer: Assessing the Value of Repeated Centralized Testing in Excision Specimens.乳腺癌中的雌激素受体、孕激素受体及人表皮生长因子受体-2检测:评估切除标本重复集中检测的价值
Appl Immunohistochem Mol Morphol. 2019 Jan;27(1):1-7. doi: 10.1097/PAI.0000000000000525.
5
Real-world data on discordance between estrogen, progesterone, and HER2 receptor expression on diagnostic tumor biopsy versus tumor resection material.关于诊断性肿瘤活检与肿瘤切除组织中雌激素、孕激素和 HER2 受体表达不一致的真实世界数据。
Breast Cancer Res Treat. 2019 Jun;175(2):451-458. doi: 10.1007/s10549-019-05141-y. Epub 2019 Feb 13.
6
Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.雌激素受体、孕激素受体及人表皮生长因子受体2在乳腺癌细针穿刺抽吸细胞块及配对组织学标本中的表达:一项大型回顾性研究。
Cancer Cytopathol. 2016 Nov;124(11):828-835. doi: 10.1002/cncy.21745. Epub 2016 Jun 17.
7
Reflex estrogen receptor/progesterone receptor/human epidermal growth factor receptor 2 (ER/PR/Her2) analysis of breast cancers in needle core biopsy specimens dramatically increases health care costs.对针芯活检标本中的乳腺癌进行雌激素受体/孕激素受体/人表皮生长因子受体2(ER/PR/Her2)反射分析会大幅增加医疗成本。
Am J Surg Pathol. 2015 Jul;39(7):939-47. doi: 10.1097/PAS.0000000000000424.
8
Concordance between core needle biopsy and surgical specimen for oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status in breast cancer.乳腺癌中雌激素受体、孕激素受体及人表皮生长因子受体2状态的粗针活检与手术标本的一致性
Singapore Med J. 2017 Mar;58(3):145-149. doi: 10.11622/smedj.2016062. Epub 2016 Mar 31.
9
Concordance between core needle biopsy and surgical excision for breast cancer tumor grade and biomarkers.核心针穿刺活检与手术切除在乳腺癌肿瘤分级和生物标志物方面的一致性。
Breast Cancer Res Treat. 2022 May;193(1):151-159. doi: 10.1007/s10549-022-06548-w. Epub 2022 Feb 28.
10
Assessment of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status in the fine needle aspirates of metastatic breast carcinomas.转移性乳腺癌细针穿刺抽吸物中雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体2(HER2)状态的评估。
Diagn Cytopathol. 2013 Apr;41(4):308-15. doi: 10.1002/dc.21841. Epub 2011 Nov 1.

引用本文的文献

1
Management of -associated breast cancer patients in low and middle-income countries: a review.低收入和中等收入国家中与……相关的乳腺癌患者的管理:一项综述。 (注:原文中“-associated”处信息不完整)
Ecancermedicalscience. 2024 Aug 22;18:1744. doi: 10.3332/ecancer.2024.1744. eCollection 2024.
2
Slide-to-Slide Tissue Transfer and Array Assembly From Limited Samples for Comprehensive Molecular Profiling.从有限的样本中进行幻灯片到幻灯片的组织转移和阵列组装,以进行全面的分子分析。
Lab Invest. 2023 May;103(5):100062. doi: 10.1016/j.labinv.2023.100062. Epub 2023 Jan 18.
3
The Impact of Pre-analytical Quality Initiatives on Cholangiocarcinoma Diagnostics in Thailand.

本文引用的文献

1
Delay to formalin fixation 'cold ischemia time': effect on ERBB2 detection by in-situ hybridization and immunohistochemistry.福尔马林固定延迟(“冷缺血时间”):对原位杂交和免疫组织化学检测 ERBB2 的影响。
Mod Pathol. 2013 Jan;26(1):1-9. doi: 10.1038/modpathol.2012.123. Epub 2012 Aug 17.
2
The effect of delay in fixation, different fixatives, and duration of fixation in estrogen and progesterone receptor results in breast carcinoma.在检测乳腺癌的雌激素和孕激素受体时,固定时间的延迟、不同的固定液以及固定时间的长短都会产生影响。
Am J Clin Pathol. 2011 Apr;135(4):592-8. doi: 10.1309/AJCPB1RIT5YXMRIS.
3
Effect of delayed formalin fixation on estrogen and progesterone receptors in breast cancer: a study of three different clones.
泰国前分析质量倡议对胆管癌诊断的影响。
Front Public Health. 2022 Jun 10;10:792847. doi: 10.3389/fpubh.2022.792847. eCollection 2022.
4
Biology of Oestrogen-Receptor Positive Primary Breast Cancer in Older Women with Utilisation of Core Needle Biopsy Samples and Correlation with Clinical Outcome.利用粗针活检样本对老年女性雌激素受体阳性原发性乳腺癌的生物学特性及其与临床结局的相关性研究
Cancers (Basel). 2020 Jul 27;12(8):2067. doi: 10.3390/cancers12082067.
5
B-cell maturation antigen expression across hematologic cancers: a systematic literature review.B 细胞成熟抗原在血液系统恶性肿瘤中的表达:系统文献回顾。
Blood Cancer J. 2020 Jun 30;10(6):73. doi: 10.1038/s41408-020-0337-y.
6
Tumor Pre-Analytics in Molecular Pathology: Impact on Protein Expression and Analysis.分子病理学中的肿瘤预分析:对蛋白质表达及分析的影响
Curr Pathobiol Rep. 2018;6(4):265-274. doi: 10.1007/s40139-018-0179-5. Epub 2018 Sep 6.
7
Breast Cancer in Low- and Middle-Income Countries: Why We Need Pathology Capability to Solve This Challenge.低收入和中等收入国家的乳腺癌:为何我们需要病理学能力来应对这一挑战。
Clin Lab Med. 2018 Mar;38(1):161-173. doi: 10.1016/j.cll.2017.10.013. Epub 2017 Dec 13.
8
Understanding preanalytical variables and their effects on clinical biomarkers of oncology and immunotherapy.了解分析前变量及其对肿瘤学和免疫治疗临床生物标志物的影响。
Semin Cancer Biol. 2018 Oct;52(Pt 2):26-38. doi: 10.1016/j.semcancer.2017.12.008. Epub 2017 Dec 16.
9
Immunohistochemistry for Pathologists: Protocols, Pitfalls, and Tips.病理学家的免疫组织化学:方案、陷阱与技巧
J Pathol Transl Med. 2016 Nov;50(6):411-418. doi: 10.4132/jptm.2016.08.08. Epub 2016 Oct 13.
10
Evaluation of three commercial progesterone receptor assays in a single tamoxifen-treated breast cancer cohort.在单一的他莫昔芬治疗的乳腺癌队列中对三种商业孕激素受体检测方法的评估。
Mod Pathol. 2016 Dec;29(12):1492-1500. doi: 10.1038/modpathol.2016.151. Epub 2016 Aug 26.
福尔马林固定时间延迟对乳腺癌中雌激素和孕激素受体的影响:三种不同克隆的研究。
Am J Clin Pathol. 2010 Nov;134(5):813-9. doi: 10.1309/AJCPVCX83JWMSBNO.
4
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.美国临床肿瘤学会/美国病理学家学院乳腺癌雌激素和孕激素受体免疫组织化学检测指南建议。
Arch Pathol Lab Med. 2010 Jun;134(6):907-22. doi: 10.5858/134.6.907.
5
Breast cancer hormone receptor assay results of core needle biopsy and modified radical mastectomy specimens from the same patients.同一患者的核心针活检和改良根治性乳房切除术标本的乳腺癌激素受体检测结果。
Clin Breast Cancer. 2010 Apr;10(2):154-9. doi: 10.3816/CBC.2010.n.021.
6
Delay to formalin fixation effect on breast biomarkers.福尔马林固定延迟对乳腺标志物的影响。
Mod Pathol. 2009 Nov;22(11):1457-67. doi: 10.1038/modpathol.2009.117. Epub 2009 Sep 4.
7
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.美国临床肿瘤学会/美国病理学家学会关于乳腺癌中人表皮生长因子受体2检测的指南建议
Arch Pathol Lab Med. 2007;131(1):18-43. doi: 10.5858/2007-131-18-ASOCCO.
8
HER2 status and benefit from adjuvant trastuzumab in breast cancer.HER2状态与乳腺癌辅助性曲妥珠单抗治疗的获益情况
N Engl J Med. 2008 Mar 27;358(13):1409-11. doi: 10.1056/NEJMc0801440.
9
Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.在一项比较来曲唑和他莫昔芬辅助治疗绝经后早期乳腺癌的随机试验(BIG 1-98)中,中心评估的雌激素和孕激素受体表达的预后及预测价值
J Clin Oncol. 2007 Sep 1;25(25):3846-52. doi: 10.1200/JCO.2007.11.9453. Epub 2007 Aug 6.
10
High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients.高孕酮受体表达与绝经前乳腺癌患者辅助性他莫昔芬的疗效相关。
Clin Cancer Res. 2006 Aug 1;12(15):4614-8. doi: 10.1158/1078-0432.CCR-06-0248.